PTEN/MMAC1 mutations found in lung cancers | Download Table
IJMS | Free Full-Text | The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer
PDF] Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations | Semantic Scholar
Cancers | Free Full-Text | Inhibition of Alternative Cancer Cell Metabolism of EGFR Mutated Non-Small Cell Lung Cancer Serves as a Potential Therapeutic Strategy
IJMS | Free Full-Text | The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer
IKKα Promotes the Progression and Metastasis of Non-Small Cell Lung Cancer Independently of its Subcellular Localization - ScienceDirect
Molecular characterization of non-small cell lung cancer tumors in Latin American patients from Brazil, Chile and Peru uncovers novel potentially driver mutations | medRxiv
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing - ScienceDirect
EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling | Cell Death & Disease
Precision Medicine in Lung Cancer: Challenges and Opportunities in Diagnostic and Therapeutic Purposes | IntechOpen
PDF) Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis
Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan‐cancer analysis - Liu - 2020 - Cancer Communications - Wiley Online Library
Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors | bioRxiv
IJMS | Free Full-Text | The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer
Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR - Ariyasu - 2021 - Cancer Science - Wiley Online Library
Proteomic and Phosphoproteomic Analyses Reveal the Oncogenic Role of PTK7-NDRG1 Axis in Non-small-cell Lung Cancer Cell Resistance to AZD9291 | ACS Chemical Biology
Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer | BMC Cancer | Full Text
Novel serum biomarkers for lung cancer early diagnosis and clinical outcome
Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation | Oncogene
Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung Cancer | SpringerLink
Immunological analysis of 98 lung adenocarcinomas by targeted gene... | Download Scientific Diagram
Frontiers | mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications
IKKα Promotes the Progression and Metastasis of Non-Small Cell Lung Cancer Independently of its Subcellular Localization - ScienceDirect
Lung Cancer - Oncologic Disorders - Pharmacotherapy A Pathophysiologic Approach, 9th Ed.